Extravascular Implantable Cardioverter-Defibrillator Device (EV-ICD)

The Aurora EV-ICD system is a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins. It delivers lifesaving defibrillation and anti-tachycardia pacing (ATP) therapy all in one system via a single implanted device that is similar in size, shape, and projected longevity to traditional, transvenous ICDs.

Since our Electrophysiology Center of Excellence team implanted the first Extravascular Implantable Cardioverter-Defibrillator (EV-ICD) device by Medtronic in the southeastern United States, “The Aurora EV-ICD system allows us to offer patients the benefits of traditional ICDs, while reducing certain risks that come with placing leads in the heart or veins,” said Dr. David Wilson, Electrophysiology Section Chief & Medical Director of the Lead Extraction and management Program at the TGH Electrophysiology Center of Excellence. “We strive to deliver high-quality patient care, and this technology is another step forward in providing our patients with the latest clinical advancements to manage their cardiac condition."